Wang Z, Zhu S, Zhao J, Nie L, et al. The heterogeneity of intraductal carcinoma of the prostate is associated with different efficacy of standard first-line therapy for patients with metastatic castration-resistant prostate cancer. Prostate 2021 Aug 26. doi: 10.1002/pros.24215.
PMID: 34435696